+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adenosine triphosphate (ATP) treatment of hypoxic pulmonary hypertension (HPH): comparison of dose dependence in pulmonary and renal circulations

Adenosine triphosphate (ATP) treatment of hypoxic pulmonary hypertension (HPH): comparison of dose dependence in pulmonary and renal circulations

Journal of Surgical Research 46(4): 374-379

In this study we investigated the relationship between pulmonary and renal responses to a low dose infusion of adenosine triphosphate-magnesium chloride (ATP-MgCl2) in a newborn piglet model of hypoxic pulmonary hypertension (HPH). Three- to five-day-old piglets were cannulated for the measurement of pulmonary and systemic arterial pressure, pulmonary and renal artery flow, and urine output. The animals were then made hypoxic by ventilation with a mixture containing 10% oxygen, 4% CO2, and balance nitrogen. Serial infusions of ATP-MgCl2 at 0.01, 0.025, 0.05, 0.1, 0.5, and 1.0 mg/kg/min were compared to preinfusion hypoxia baselines. Hypoxia alone produced a significant elevation in pulmonary artery pressure (73%) and a reduction in pO2. All dose rates of ATP-MgCl2 greater than or equal to 0.05 mg/kg/min produced a significant decrease in mean pulmonary artery pressure. However, as baseline mean pulmonary artery pressure increased there was an increased sensitivity to ATP-induced vasodilation. Pulmonary artery flow did not change during ATP infusion, thus, the change in pulmonary vascular resistance accounted for the decrease in pulmonary artery pressure. In contrast to the response of the pulmonary vasculature, systemic pressure was significantly decreased only during the 1.0 mg/kg/min infusion. Renal blood flow decreased by 46% during hypoxia and decreased further only during the highest dose rate of ATP infused (i.e., 1.0 mg/kg/min). Creatinine clearance (Ccr) and fractional reabsorption of Na (FreNa) also fell during hypoxia, but were not further altered during all but the highest dose of ATP infused.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 039187293

Download citation: RISBibTeXText

PMID: 2704234

DOI: 10.1016/0022-4804(89)90205-9

Related references

Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension. Journal of Pediatric Surgery 23(12): 1154-1160, 1988

Comparison of pulmonary and systemic effects of adenosine triphosphate in chronic obstructive pulmonary disease--ATP: a pulmonary controlled vasoregulator?. European Respiratory Journal 3(4): 450-455, 1990

Dose-related response of adenosine in hypoxic pulmonary hypertension in canines. Hua Xi Yi Ke Da Xue Xue Bao 30(2): 162-4, 173, 2002

Adenosine triphosphate treatment for meconium aspiration-induced pulmonary hypertension in pigs. Acta Physiologica Scandinavica 160(3): 283-289, 1997

Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology 49(4): 609-618, 2014

Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology 47(2): 140-148, 2013

Serotonin receptors take the TRiPV4 highway in chronic hypoxic pulmonary hypertension. Focus on "TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension". American Journal of Physiology. Cell Physiology 305(7): C690-C692, 2013

Effect of a single dose of nifedipine on hemodynamic parameters of pulmonary circulation and left-ventricular function in patients with hypoxic pulmonary hypertension. Kardiologia Polska 31(10): 621-625, 1988

Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: a pulmonary vasoregulator?. American Review of Respiratory Disease 134(6): 1140-1144, 1986

Phosphodiesterase inhibitors on pulmonary arteries from rats with hypoxic pulmonary hypertension Comparison off 1 and 4 weeks of hypoxia. British Journal of Pharmacology 122(PROC SUPPL ): 375P, 1997

Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats. Canadian Journal of Physiology & Pharmacology 79(3): 227-237, 2001

Adenosine does not mediate the pulmonary vasodilator response of adenosine 5'-triphosphate in the feline pulmonary vascular bed. Journal of Pharmacology and Experimental Therapeutics 250(1): 170-176, 1989

Chronic pharmacologic treatment of experimental hypoxic pulmonary hypertension with observations on rate of change in pulmonary arterial pressure. American Heart Journal 72(1): 50-59, 1966

Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial. European Heart Journal 36(46): 3276-3287, 2016

β2-Adrenergic receptor-dependent attenuation of hypoxic pulmonary vasoconstriction prevents progression of pulmonary arterial hypertension in intermittent hypoxic rats. Plos One 9(10): E110693, 2015